Investors

Midatech Pharma PLC (dual listed on LSE AIM: MTPH; and NASDAQ: MTP) is a drug delivery technology company focused on improving the bio-delivery and bio-distribution of medicines.

Analyst Coverage

Midatech is covered by the following research analysts:

Analyst: Mike Mitchell

Panmure Gordon (UK) Limited
One New Change
London
EC4M 9AF
United Kingdom
+44 (0)20 7886 2500

Analyst: Barry Gibb

Turner Pope Investments Limited
8 Frederick’s Place
London
EC2R 8AB
+44 (0) 20 3657 0050

Analyst: Max Jacobs

Edison Investment Research Limited
London
WC1V 7EE
+44 (0) 20 3077 5700

Please note that any opinions, estimates or forecasts made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Midatech or its management. Requests for copies of analyst reports should be directed at the respective analyst and institution.